News

A deadly form of children’s brain cancer that’s immune to chemotherapy is the target of new research at Hudson Institute, looking at the epigenome and immuno-therapies for answers.…  Read more

Every mother wants to have the healthiest child she can, and new research shows that the nutritional status of the mother during pregnancy can affect outcomes for the baby – with male and female offspring affected differently.…  Read more

Correct development of testes in a male foetus – and fertility later in life – depend on a crucial hormone being at just the right level.…  Read more

Hudson Institute of Medical Research today officially unveiled its world-first RNAte platform that could see vaccines and therapeutic treatments developed faster by being able to rapidly assess their potential inflammation side effects, right here in Victoria.…  Read more

A new treatment that controls the body’s response to influenza virus is shaping as the key to preventing dangerous lung inflammation and damage.…  Read more

Hudson Institute researchers have had some great success in the recent NHMRC Grant rounds.…  Read more

Exciting research projects covering healthier pregnancy, safer birth and new forms of cancer treatment have attracted major funding in the form of NHMRC Investigator grants.…  Read more

Hudson Institute’s world leading inflammation programs enter a new era with the appointment of Professor Seth Masters to lead the Centre for Innate Immunity and Infectious Diseases (CiiiD).…  Read more

A researcher leading the most exciting project in search of a fix for pelvic organ prolapse (POP) has been awarded a prestigious fellowship to advance her work.…  Read more

H. pylori – short for Helicobacter pylori – colonises the stomach and is known to be linked to the development of stomach cancer. It is estimated that over half of the world’s population is infected with H. pylori, making it one of the most common bacterial infections.…  Read more